GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » PEG Ratio

Hansoh Pharmaceutical Group Co (HKSE:03692) PEG Ratio : 5.13 (As of May. 04, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Hansoh Pharmaceutical Group Co's PE Ratio without NRI is 33.35. Hansoh Pharmaceutical Group Co's 5-Year EBITDA growth rate is 6.50%. Therefore, Hansoh Pharmaceutical Group Co's PEG Ratio for today is 5.13.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Hansoh Pharmaceutical Group Co's PEG Ratio or its related term are showing as below:

HKSE:03692' s PEG Ratio Range Over the Past 10 Years
Min: 1.41   Med: 2.33   Max: 5.13
Current: 5.13


During the past 8 years, Hansoh Pharmaceutical Group Co's highest PEG Ratio was 5.13. The lowest was 1.41. And the median was 2.33.


HKSE:03692's PEG Ratio is ranked worse than
81.79% of 368 companies
in the Drug Manufacturers industry
Industry Median: 1.755 vs HKSE:03692: 5.13

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Hansoh Pharmaceutical Group Co PEG Ratio Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co PEG Ratio Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - 2.29 3.25 4.43

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 - 3.25 - 4.43

Competitive Comparison of Hansoh Pharmaceutical Group Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's PEG Ratio falls into.



Hansoh Pharmaceutical Group Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Hansoh Pharmaceutical Group Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=33.345521023766/6.50
=5.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Hansoh Pharmaceutical Group Co  (HKSE:03692) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Hansoh Pharmaceutical Group Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines